Literature DB >> 12233943

Steroid use during pregnancy.

Deborah Cooper McGee1.   

Abstract

Health care providers and pregnant women share a concern for protecting the fetus from unnecessary and potentially teratogenic influences. Since the introduction of steroids for the induction of fetal surfactant production, there has been considerable experience in the use of corticosteroids during pregnancy. While the use of corticosteroids for surfactant induction in the preterm fetus has become commonplace, steroids are used for other obstetric and medical indications during pregnancy. Thus, finding a balance between drug benefits and possible side effects remains a critical issue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12233943     DOI: 10.1097/00005237-200209000-00004

Source DB:  PubMed          Journal:  J Perinat Neonatal Nurs        ISSN: 0893-2190            Impact factor:   1.638


  4 in total

Review 1.  A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes.

Authors:  Gretchen Bandoli; Kristin Palmsten; Chelsey J Forbess Smith; Christina D Chambers
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  Fetal adrenal suppression due to maternal corticosteroid use: case report.

Authors:  Selim Kurtoğlu; Dilek Sarıcı; Mustafa Ali Akın; Ghaniya Daar; Levent Korkmaz; Şeyma Memur
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

3.  Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study.

Authors:  Anne-Mette B Bjørn; Rikke B Nielsen; Mette Nørgaard; Ellen A Nohr; Vera Ehrenstein
Journal:  Clin Epidemiol       Date:  2013-08-14       Impact factor: 4.790

4.  Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines.

Authors:  Hye Lim Lee; Su-Hyun Kim; Jin Myoung Seok; Byung Jo Kim; Ho Jin Kim; Byoung Joon Kim
Journal:  J Clin Neurol       Date:  2022-03       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.